These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22555943)

  • 21. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary revascularization in ischemic cardiomyopathy.
    Westaby S
    Surg Clin North Am; 2004 Feb; 84(1):179-99, x. PubMed ID: 15053189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revascularization interventions for ischemic heart disease.
    Moustapha A; Anderson HV
    Curr Opin Cardiol; 2000 Nov; 15(6):463-71. PubMed ID: 11198628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcomes for ischemic heart disease in dialysis-dependent patients.
    Yeates A; Hawley C; Mundy J; Pinto N; Haluska B; Shah P
    Asian Cardiovasc Thorac Ann; 2012 Jun; 20(3):281-91. PubMed ID: 22718716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
    Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
    Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
    J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silent ischemia: clinical relevance.
    Conti CR; Bavry AA; Petersen JW
    J Am Coll Cardiol; 2012 Jan; 59(5):435-41. PubMed ID: 22281245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Brooks MM; Chaitman BR; Nesto RW; Hardison RM; Feit F; Gersh BJ; Krone RJ; Sako EY; Rogers WJ; Garber AJ; King SB; Davidson CJ; Ikeno F; Frye RL;
    Circulation; 2012 Oct; 126(17):2115-24. PubMed ID: 23008442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.
    Ujueta F; Weiss EN; Shah B; Sedlis SP
    Curr Cardiol Rep; 2017 Feb; 19(2):17. PubMed ID: 28213668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease.
    Volodarskiy A; Kumar S; Amin S; Bangalore S
    Am J Med; 2016 Dec; 129(12):1288-1298. PubMed ID: 27476086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery.
    Thielmann M; Massoudy P; Jaeger BR; Neuhäuser M; Marggraf G; Sack S; Erbel R; Jakob H
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):117-25. PubMed ID: 16723243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of variations in initial treatment strategies for stable ischemic heart disease.
    Bennell MC; Qiu F; Kingsbury KJ; Austin PC; Wijeysundera HC
    CMAJ; 2015 Jul; 187(10):E317-E325. PubMed ID: 25991840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after coronary revascularization in the elderly.
    Graham MM; Ghali WA; Faris PD; Galbraith PD; Norris CM; Knudtson ML;
    Circulation; 2002 May; 105(20):2378-84. PubMed ID: 12021224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ; Novak E; Brown DL
    Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.